title: The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread.
abstract: Bordering the ventricular cerebrospinal fluid (CSF) are epithelial cells of choroid plexus (CP), ependyma and circumventricular organs (CVOs) that contain homeostatic transporters for mediating secretion/reabsorption. The distributional pathway ("nexus") of CP-CSF-ependyma-brain furnishes peptides, hormones, and micronutrients to periventricular regions. In disease/toxicity, this nexus becomes a conduit for infectious and xenobiotic agents. The sleeping sickness trypanosome (a protozoan) disrupts CP and downstream CSF-brain. Piperamide is anti-trypanosomic but distorts CP epithelial ultrastructure by engendering hydropic vacuoles; this reflects phospholipidosis and altered lysosomal metabolism. CP swelling by vacuolation may occlude CSF flow. Toxic drug tools delineate injuries to choroidal compartments: cyclophosphamide (vasculature), methylcellulose (interstitium), and piperazine (epithelium). Structurally perturbed CP allows solutes to penetrate the ventricles. There, CSF-borne pathogens and xenobiotics may permeate the ependyma to harm neurogenic stem cell niches. Amoscanate, an anti-helmintic, potently injures rodent ependyma. Ependymal/brain regions near CP are vulnerable to CSF-borne toxicants; this proximity factor links regional barrier breakdown to nearby periventricular pathology. Diverse diseases (e.g., African sleeping sickness, multiple sclerosis) take early root in choroidal, circumventricular, or perivascular loci. Toxicokinetics informs on pathogen, anti-parasitic agent, and auto-antibody distribution along the CSF nexus. CVOs are susceptible to plasma-borne toxicants/pathogens. Countering the physico-chemical and pathogenic insults to the homeostasis-mediating ventricle-bordering cells sustains brain health and fluid balance.
authors.affiliation: Brown University, Providence, RI 02903, United States. Conrad_Johanson@Brown.edu
authors.forename: Conrad
authors.initials: C
authors.lastname: Johanson
authors.forename: Edward
authors.initials: E
authors.lastname: Stopa
authors.forename: Paul
authors.initials: P
authors.lastname: McMillan
authors.forename: Daniel
authors.initials: D
authors.lastname: Roth
authors.forename: Juergen
authors.initials: J
authors.lastname: Funk
authors.forename: Georg
authors.initials: G
authors.lastname: Krinke
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000493:pharmacokinetics; D001812:Blood-Brain Barrier / Q000502:physiology*; D001921:Brain / Q000378:metabolism; D002493:Central Nervous System Diseases / Q000473:pathology; D002552:Cerebral Ventricles / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000378:metabolism*; D002831:Choroid Plexus / Q000098:blood supply* / Q000166:cytology / Q000378:metabolism; D004159:Diphenylamine / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D004805:Ependyma / Q000166:cytology / Q000378:metabolism*; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D017879:Isothiocyanates / Q000493:pharmacokinetics; D020258:Neurotoxicity Syndromes / Q000473:pathology; D014882:Water-Electrolyte Balance
chemical_list: D000871:Anthelmintics; D017879:Isothiocyanates; D004159:Diphenylamine; C012391:amoscanate